Roth Capital upgraded shares of Cresco Labs (OTCMKTS:CRLBF – Free Report) to a strong-buy rating in a research note published on Sunday,Zacks.com reports.
Several other analysts also recently issued reports on the stock. Needham & Company LLC reissued a “hold” rating on shares of Cresco Labs in a research note on Monday, August 12th. Ventum Cap Mkts raised shares of Cresco Labs to a “strong-buy” rating in a research note on Friday, August 9th. Two equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $2.50.
View Our Latest Report on CRLBF
Cresco Labs Stock Down 16.1 %
Cresco Labs (OTCMKTS:CRLBF – Get Free Report) last announced its quarterly earnings data on Friday, November 8th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.01). The firm had revenue of $179.78 million during the quarter, compared to the consensus estimate of $185.23 million. Cresco Labs had a negative return on equity of 17.03% and a negative net margin of 23.07%. Research analysts anticipate that Cresco Labs will post -0.15 earnings per share for the current year.
About Cresco Labs
Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.
Read More
- Five stocks we like better than Cresco Labs
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- These 3 Active ETFs Beat the S&P 500 Over the Last Five Years
- What Are Dividend Champions? How to Invest in the Champions
- 3 Top Stocks Crushing Q3 Earnings With Strong 2024 Guidance
- Manufacturing Stocks Investing
- Lam Research Fueled by Unyielding AI Demand Growth
Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.